An updated version of OnGuard, Riverain’s computer-aided lung cancer detection device, has been approved by the US Food and Drug Administration (FDA).
OnGuard Chest X-ray Computer-Aided Detection helps physicians identify suspicious nodules in the lungs earlier using pattern recognition and machine-learning technology.
This version of the OnGuard device has been found to improve sensitivity by 50% and reduce false positive marks by 73%, according to a trial conducted by manufacturer Riverain.
OnGuard is compatible with the existing digital chest X-ray, so no additional radiation dose, patient procedure, hardware or stand-alone workstation is required to integrate the technology into radiology departments.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below formBy GlobalData